Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000147560 | SCV000195008 | pathogenic | Congenital muscular hypertrophy-cerebral syndrome | 2014-05-01 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000147560 | SCV000760987 | pathogenic | Congenital muscular hypertrophy-cerebral syndrome | 2020-01-07 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine with tryptophan at codon 790 of the SMC1A protein (p.Arg790Trp). The arginine residue is highly conserved and there is a moderate physicochemical difference between arginine and tryptophan. This variant is not present in population databases (ExAC no frequency). This variant has been reported to be de novo in an individual affected with Cornelia de Lange syndrome (PMID: 25125236). ClinVar contains an entry for this variant (Variation ID: 159950). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. A different missense substitution at this codon (p.Arg790Gln) has been determined to be pathogenic (PMID: 17273969, 25125236). This suggests that the arginine residue is critical for SMC1A protein function and that other missense substitutions at this position may also be pathogenic. For these reasons, this variant has been classified as Pathogenic. |
Ambry Genetics | RCV001265874 | SCV001444046 | likely pathogenic | Inborn genetic diseases | 2018-03-14 | criteria provided, single submitter | clinical testing | |
Department of Pediatrics, |
RCV001252688 | SCV001163831 | likely pathogenic | Microcephaly | no assertion criteria provided | research |